Table 1 Characteristics of study population
All patients (n = 145) | VAI ≥ grade 3* (n = 72) | VAI < grade 3* (n = 73) | p value | |||||
|---|---|---|---|---|---|---|---|---|
n | % | n | % | N | % | |||
Females | 34 | 23% | 15 | 21% | 19 | 26% | 0.5573 | |
Age in years, median (range) | 68 (27–91) | 69 (42–88) | 68 (27–91) | 0.2578 | ||||
BMI in kg/m2, median (range) | 27 (17–53) | 26 (18–37) | 28 (17–53) | 0.9330 | ||||
CRP in mg/L, median (range) | 8.565 (0–289) | 8.860 (0–289) | 8.490 (0–234) | 0.7181 | ||||
Indication for MRA | ||||||||
Suspected PAD | 12 | 8% | 6 | 8% | 6 | 8% | 1.0000 | |
Known PAD | 133 | 92% | 66 | 92% | 67 | 92% | ||
Patients with information on Fontaine stage of PAD (n = 121) | ||||||||
Fontaine stage IIa | 3 | 2% | 2 | 3% | 1 | 2% | 0.2535 | |
Fontaine stage IIb | 64 | 53% | 35 | 58% | 29 | 48% | ||
Fontaine stage III | 10 | 8% | 3 | 5% | 7 | 11% | ||
Fontaine stage IV | 44 | 36% | 20 | 33% | 24 | 39% | ||
Cardio-vascular risk factors | ||||||||
Smoking | 45 | 31% | 26 | 36% | 19 | 26% | 0.2122 | |
Diabetes | 54 | 37% | 27 | 38% | 27 | 37% | 1.0000 | |
Arterial hypertension | 83 | 57% | 44 | 61% | 40 | 55% | 0.5022 | |
Hyperlipidaemia | 61 | 42% | 25 | 35% | 36 | 49% | 0.0930 | |
Vascular comorbidities | ||||||||
Coronary artery disease | 39 | 27% | 22 | 31% | 16 | 22% | 0.2616 | |
Cerebrovascular disease | 12 | 8% | 6 | 8% | 5 | 7% | 0.7646 | |